Linkedin Facebook Contact with Pharma Industrial India
 

Last edition

July-August, 2026
All magazines
Subscribe to our magazine
autodoc
 
Home › News › Regulation

Biocon Malaysia Gets MHRA Approval for Insulin Unit

Biocon Malaysia Gets MHRA Approval for Insulin Unit

Biocon has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA), UK for its new drug product fill finish unit for Semglee (insulin glargine) at its insulin manufacturing facility in Malaysia.

In July, Biocon had secured regulatory approval from the European Medicines Agency (EMA) for this new drug product fill-finish line.

Supplies to Europe from this line were expected to begin from Q2FY27.
Read more on:
Biocon insulin manufacturing Biocon Malaysia insulin facility Biocon MHRA approval Biocon Semglee approval MHRA approval for insulin Semglee European supply Semglee insulin glargine
More news about: regulation | Published by News Bureau | September - 25 - 2026

Last news about this category

US FDA Approves Lirafugratinib for Cholangiocarcinoma US FDA Approves Lirafugratinib for Cholangiocarcinoma
EU Approves Trixeo for Asthma Maintenance Treatment EU Approves Trixeo for Asthma Maintenance Treatment
Glenmark Goa Plant Gets VAI Status from US FDA Glenmark Goa Plant Gets VAI Status from US FDA
US FDA Grants Priority Review to Insmed's sNDA for ARIKAYCE US FDA Grants Priority Review to Insmed's sNDA for ARIKAYCE
US FDA Approves Finerenone for CKD in Type 1 Diabetes US FDA Approves Finerenone for CKD in Type 1 Diabetes
US FDA Approves Inluriyo in Combination with Verzenio US FDA Approves Inluriyo in Combination with Verzenio
Biocon's Pertuzumab Gets EMA CHMP Approval Nod Biocon's Pertuzumab Gets EMA CHMP Approval Nod
Ultragenyx Gets US FDA Nod for First MPS IIIA Gene Therapy Ultragenyx Gets US FDA Nod for First MPS IIIA Gene Therapy
US FDA OKs First Gene Therapy for Sanfilippo Syndrome A US FDA OKs First Gene Therapy for Sanfilippo Syndrome A
Ono Pharmaceuticals Gets Nod for XCOPRI Tablets in Japan Ono Pharmaceuticals Gets Nod for XCOPRI Tablets in Japan
 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members

Privacy Policy | Cookies Policy